Published April 2, 2024
| Version v1
Patent
Open
Beta-catenin inhibitors in cancer immunotherapy
Contributors
Patent applicant:
Description
Provided herein are compositions and methods for the treatment of cancer by inhibition of β-catenin or a β-catenin pathway. In particular, inhibitors of β-catenin and/or the Wnt/β-catenin signaling pathway are employed prevent or reverse evasion of immune response or immunotherapy by cancers.
Files
US_11946936_B2.pdf
Files
(3.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:5107782ff6f1b39c3b00c80281529828
|
3.7 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 11946936 B2
- Patent application number
- 202016933614
- Other
- oai:uchicago.tind.io:12999
Dates
- Patent filed
-
2020-07-20